Equity
€502,745 ▲ 40.9%
DOCTEUR ALINE BAUDUIN has made a profit without a break since 2008.
DOCTEUR ALINE BAUDUIN
Lifetime
20 annual accounts with figures on one time axis, 22 filings since 2004peak €281,070 (2025)
€281,070▲ 67.5%
lowest -€33,205 (2007)
€145,823▲ 168%
peak €502,745 (2025)
€502,745▲ 40.9%
€1.1m▲ 64.4%
peak 2 FTE (2016)
-not published
Board1 name since 2021
1 directorBAUDUIN Aline Marie Alberte Noëlla
Documentsfilings and deeds
14-09-202645 days late
2025micro format
Gross margin from €167,818 to €281,070Result from €54,388 to €145,823Equity from €356,922 to €502,745Debts from €686,501 to €1.1mInvestments €672,826
Key points
from the 2025 annual accountsResult
€145,823 ▲ 168%
The result rose in 2025: mostly from a one-off income of €165,582.
Turnover
≈ €560,000 estimated
The micro format states no turnover.
Debts
€1.1m ▲ 64.4%
Debts rose by €442,015 in 2025.
Investments
€834,412 13.8 × depreciation
Green is investment, beige is depreciation. Land and buildings stand 75.3% higher than in 2024.
Filings
22 annual accounts since 2004
Eight of the last ten came late. The 2020 accounts came latest: 87 days after the end of the period.
Checked score
87
Excellent
Financially stronger than 57% of micro companies without a NACE code
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%lowest value
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025
07-2025: 0.2%▲ +0.1 percentage points vs 06-2025
08-2025: 0.1%▼ -0.1 percentage points vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.4%▲ +0.3 percentage points vs 07-2026highest value
09-2026: 0.1%▼ -0.3 percentage points vs 08-2026
10-2026: 0.3%▲ +0.2 percentage points vs 09-2026
11-2026: 0.3%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Last filed accounts filed 45 days late; 1 of the last 3 accounts late
No registered site in the KBO
Liquidity: current ratio 0.92, cash €56,375
lowers risk
Size: total assets €1.6m
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 33% of them on solvency, 49% on liquidity, 63% on profitability and 84% on growth.
The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 20,137 companies had the same profile as DOCTEUR ALINE BAUDUIN has now. Each dot stands for 51 companies, two years later.
95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
That fits the bankruptcy probability of DOCTEUR ALINE BAUDUIN itself: 0.3% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 20,137 companies, not a prediction for DOCTEUR ALINE BAUDUIN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €40,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.92 (1.3 in 2024), below 1. Short-term debt is 10.2% and cash 3.5% of total assets. 69.2% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 45 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-09-2026, 45 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
45 days late
2024
9 days early
2023
29 days late
2022
14 days early
2021
29 days late
2020
87 days late
2019
31 days late
← before the deadline
after the deadline →
tick = median of all Belgian filings
The company filed its last 7 accounts on average 28 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 August (4 of the last 5 accounts filed within 38 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
06-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Change of role: BAUDUIN Aline Marie Alberte Noëlla, from manager to director
BAUDUIN Aline Marie Alberte Noëlla holds 186 shares · Director discharge: BAUDUIN Aline Marie Alberte Noëlla · General meeting of 29-03-2024 · Gazette deed
Incorporation
published on 15-04-2004 · Gazette deed
Official details
Source: KBO- Status
- Active since 01-04-2004Normal situation
- Activity
- “En assurant la gestion d'un ou plusieurs centres médicaux ou d'un ou plusieurs cabinets…” (deed in French)From the articles, 3 activitiesNo NACE code in the KBO yet
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Insights on DOCTEUR ALINE BAUDUIN
DOCTEUR ALINE BAUDUIN files the micro format. That format states no turnover. The gross margin rose from €186,676 in 2006 to €281,070 in 2025.
The balance sheet grew most from 2023 to 2025 through fixed assets, financed with long-term debt.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DOCTEUR ALINE BAUDUIN
- What is the company number of DOCTEUR ALINE BAUDUIN?
- The company number of DOCTEUR ALINE BAUDUIN is 0864.481.123. The VAT number is the same number with BE in front: BE 0864.481.123.
- Where is DOCTEUR ALINE BAUDUIN based?
- The registered office is at Rue Albert 1er 21, 6280 Gerpinnes.Company details
- What is the legal form of DOCTEUR ALINE BAUDUIN?
- DOCTEUR ALINE BAUDUIN is a private limited company (BV).
- When was DOCTEUR ALINE BAUDUIN founded?
- DOCTEUR ALINE BAUDUIN was founded on 01-04-2004.
- Is DOCTEUR ALINE BAUDUIN still active?
- Yes, DOCTEUR ALINE BAUDUIN is an active enterprise in the KBO register.
- How many employees does DOCTEUR ALINE BAUDUIN have?
- DOCTEUR ALINE BAUDUIN had an average of 0.7 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
- What is the turnover of DOCTEUR ALINE BAUDUIN?
- The turnover in financial year 2025 is ≈ €560,000. This figure is estimated from the gross margin of €281,070 and 880 comparable companies of the same size. It probably lies between €390,000 and €820,000. It is a rough estimate.
- Is DOCTEUR ALINE BAUDUIN profitable?
- In financial year 2025, DOCTEUR ALINE BAUDUIN made a profit of €145,823.
- Where can I find the annual accounts of DOCTEUR ALINE BAUDUIN?
- DOCTEUR ALINE BAUDUIN filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DOCTEUR ALINE BAUDUIN due?
- DOCTEUR ALINE BAUDUIN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.